CORE
发表于 2025-3-30 10:28:23
Novel Antibiotics in Urologye last 10 years are considered including one new siderophore cephalosporin, two new carbapenems, three cephalosporin/beta-lactamase inhibitor and two carbapenem/beta-lactamase inhibitor combinations, one novel aminoglycoside, two new fluoroquinolones, a new tetracycline, and the revival of the parenteral fosfomycin disodium.
Encumber
发表于 2025-3-30 12:39:09
http://reply.papertrans.cn/40/3908/390776/390776_52.png
姑姑在炫耀
发表于 2025-3-30 17:16:56
http://reply.papertrans.cn/40/3908/390776/390776_53.png
丰满中国
发表于 2025-3-31 00:43:58
http://reply.papertrans.cn/40/3908/390776/390776_54.png
GRATE
发表于 2025-3-31 04:09:05
http://reply.papertrans.cn/40/3908/390776/390776_55.png
刺穿
发表于 2025-3-31 06:26:02
The Treatment of Urinary Tract Infections Caused by ESBL-Producing Gram-Negative Bacteria, Vancomyciatients with urinary tract infections (UTI) caused by ESBL, VRE, and MDR bacteria..This chapter aims to comprehensively discuss current antibacterial treatment options for uncomplicated and complicated UTI caused by multiresistant microorganisms and to provide an overview of currently available as well as upcoming therapeutic options.
臆断
发表于 2025-3-31 10:28:27
Bacteriophage Therapy for Urinary Tract Infections., we delve into the specific clinical applications of phages for treating urinary tract infections (UTIs) in patients and provide our perspective on the future of phage therapy in combating urological infections.